"49502-475-93" National Drug Code (NDC)

Symfi 1 BOTTLE, PLASTIC in 1 CARTON (49502-475-93) > 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
(Mylan Specialty L.P.)

NDC Code49502-475-93
Package Description1 BOTTLE, PLASTIC in 1 CARTON (49502-475-93) > 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Product NDC49502-475
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameSymfi
Non-Proprietary NameEfavirenz, Lamivudine And Tenofovir Disoproxil Fumarate
Dosage FormTABLET, FILM COATED
UsageORAL
Start Marketing Date20180425
Marketing Category NameNDA
Application NumberNDA022142
ManufacturerMylan Specialty L.P.
Substance NameEFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Strength600; 300; 300
Strength Unitmg/1; mg/1; mg/1
Pharmacy ClassesCytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/49502-475-93